Stock ISLT ISLET SCIENCES INC
Add to a list
To use this feature you must be a member
Log inSign up

Islet Sciences Inc Stock

Equities

ISLT

US46467R1095

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 09:53:58 2017-07-26 EDT 		5-day change 1st Jan Change
0.0127 USD +5.75% Intraday chart for Islet Sciences Inc +5.75% -76.93%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Chart Islet Sciences Inc

Dynamic Chart

Press releases Islet Sciences Inc

Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH GL
Islet Sciences, Inc. Presented at 50th International Liver Conference GL
Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum GL
Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH) GL
Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD GL
More press releases

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+41.79% 50.93B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.56% 42.12B
LONZA GROUP AG Stock Lonza Group AG
+49.62% 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
-7.20% 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.59% 26.02B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.51% 18.9B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+6.92% 13.21B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.91% 12.17B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.60% 12.16B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ISLT Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW